Belgium· BE-AMP-SAM663318-00
Nuvaxovid XBB.1.5
A covid-19, protein-untereinheit product containing covid-19 vaccine (nvx-cov2373 [recombinant, adjuvanted]), registered in Belgium by Sanofi Winthrop Industrie. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Covid-19, protein-untereinheit is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BN04 (covid-19, protein-untereinheit), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Covid-19, protein-untereinheit · ATC J07BN04
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- COVID-19 Vaccine (NVX-CoV2373 [Recombinant, Adjuvanted])
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Belgium (BE)
- ATC code
- J07BN04
- ATC class
- Covid-19, Protein-Untereinheit
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BN04
Covid-19, protein-untereinheit, as other registers publish it.
- BelgiumBimervaxHipra Human Health
- PolandBimervaxHipra Human Health, S.L.U.
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- IcelandBIMERVAXHipra Human Health S.L.
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- FinlandBIMERVAXHipra Human Health S.L.
- DenmarkBIMERVAXHipra Human Health S.L.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b752c82b-01f6-4c15-8524-bbd492ce3d3d GET /v1/drugs/b752c82b-01f6-4c15-8524-bbd492ce3d3d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispersion for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Nuvaxovid XBB.1.5",
"name_fr": "Nuvaxovid XBB.1.5",
"name_nl": "Nuvaxovid XBB.1.5",
"amp_code": "SAM663318-00",
"strengths": [
"5.0000",
"5.0000",
"5.0000"
],
"pack_count": 2,
"substances": [
"COVID-19 Vaccine (NVX-CoV2373 [Recombinant, Adjuvanted])",
"COVID-19 Vaccine (NVX-CoV2601 [Recombinant, Adjuvanted]), Mivalsecovatein",
"Disodium Hydrogen Phosphate Heptahydrate",
"Disodium Hydrogen Phosphate Dihydrate",
"Potassium Chloride",
"Potassium Dihydrogen Phosphate",
"Sodium Dihydrogen Phosphate Monohydrate",
"Sodium Chloride",
"Sodium Hydroxide",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Covid-19, Protein Subunit",
"authorisation_numbers": [
"EU/1/21/1618/010",
"EU/1/21/1618/005"
]
}See everything about covid-19, protein-untereinheit.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.